Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00081055
Status:
WITHDRAWN
Last Update Posted:
2014-12-04
First Post:
2004-04-07
Brief Title:
OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies
Sponsor:
Mesoblast International Sàrl
Organization:
Mesoblast Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndromes |
| Graft Versus Host Disease |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| graft versus host disease | View |
| adult acute lymphoblastic leukemia in remission | View |
| recurrent adult acute lymphoblastic leukemia | View |
| adult acute myeloid leukemia in remission | View |
| recurrent adult acute myeloid leukemia | View |
| accelerated phase chronic myelogenous leukemia | View |
| chronic phase chronic myelogenous leukemia | View |
| refractory anemia | View |
| refractory anemia with excess blasts | View |
| refractory anemia with ringed sideroblasts | View |
| de novo myelodysplastic syndromes | View |
| previously treated myelodysplastic syndromes | View |
| secondary myelodysplastic syndromes | View |
| adult acute myeloid leukemia with t821q22q22 | View |
| adult acute myeloid leukemia with t1616p13q22 | View |
| adult acute myeloid leukemia with inv16p13q22 | View |
| adult acute myeloid leukemia with 11q23 MLL abnormalities | View |
| adult acute myeloid leukemia with t1517q22q12 | View |